Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial.

Saved in:
Bibliographic Details
Title: Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial.
Authors: Denormandie P; Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, France (P.D., N.D., E.P.).; Université de Paris, France (P.D.)., Simon T; AP-HP, Hôpital Saint Antoine, Department of Clinical Pharmacology and Unité de Recherche Clinique (URCEST), Paris, France (T.S.).; Université Pierre et Marie Curie (UPMC-Paris 06) (T.S.).; INSERM U-698, Paris, France (T.S.).; French Alliance for Cardiovascular Trials (T.S., P.G.S., F.S., G.V.)., Cayla G; Cardiology Department, Nîmes University Hospital, Montpellier University, France (G.C.)., Steg PG; French Alliance for Cardiovascular Trials (T.S., P.G.S., F.S., G.V.).; INSERM Unité-1148, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Université de Paris, France (P.G.S.)., Montalescot G; Sorbonne Université, ACTION Study Group, Institut de Cardiologie (APHP), INSERM UMRS 1166, Hôpital Pitié-Salpêtrière, Paris, France (G.M.)., Durand-Zaleski I; Clinical Research Unit Eco Ile de France, Hôpital Hôtel Dieu, AP-HP, Paris (I.D.-Z., A.l.B.)., le Bras A; Clinical Research Unit Eco Ile de France, Hôpital Hôtel Dieu, AP-HP, Paris (I.D.-Z., A.l.B.)., le Breton H; Université Rennes, CHU Rennes, Inserm, LTSI-UMR1099, France (H.l.B.)., Valy Y; Department of Cardiology, CH Saint-Louis, La Rochelle, France (Y.V.)., Schiele F; French Alliance for Cardiovascular Trials (T.S., P.G.S., F.S., G.V.).; Department of Cardiology, University Hospital Besançon, France (F.S.).; EA 3920, University of Burgundy Franche-Comté, Besançon, France (F.S.)., Cuisset T; ACTION Study Group, Cardiology Department, INSERM UMR1062, INRA UMR1260, Centre Hospitalier Universitaire La Timone, Aix-Marseille University, France (T.C.)., Vanzetto G; French Alliance for Cardiovascular Trials (T.S., P.G.S., F.S., G.V.).; Department of Cardiology, University Hospital, 38000 Grenoble Alpes, France (G.V.).; INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble Alpes University, France (G.V.)., Levesque S; Cardiovascular Interventional Unit, Division of Cardiology, Department of Medicine, Centre Cardio-Vasculaire, CHU de Poitiers, France (S.L.)., Goube P; Department of Cardiology, Centre Hospitalier Sud Francilien, Corbeil Essonne, France (P.G.)., Nallet O; Cardiology Department, Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, France (O.N.)., Angoulvant D; Cardiology Department and EA4245 T2i, University Hospital of Tours and Tours University, France (D.A.)., Roubille F; Department of Cardiology, Regional University Hospital of Montpellier, France (F.R.).; PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, France (F.R.)., Charles Nelson A; Clinical Research Unit and CIC 1418 INSERM, George-Pompidou European Hospital, AP-HP, Paris, France (A.C.N., G.C.)., Chatellier G; Clinical Research Unit and CIC 1418 INSERM, George-Pompidou European Hospital, AP-HP, Paris, France (A.C.N., G.C.)., Danchin N; Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, France (P.D., N.D., E.P.)., Puymirat E; Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, France (P.D., N.D., E.P.).
Source: Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2021 Nov; Vol. 14 (11), pp. e011314. Date of Electronic Publication: 2021 Aug 23.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101499602 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-7632 (Electronic) Linking ISSN: 19417640 NLM ISO Abbreviation: Circ Cardiovasc Interv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1941-7632
DOI:10.1161/CIRCINTERVENTIONS.121.011314